GlaxoSmithKline PLC

Pharmaceuticals
United Kingdom
2016 Revenue (US$ Millions)$34,307
Revenue Growth (%)16.58%
Net Income (US$ Millions)$1,122
Earnings Per Share (US$)$0.23
EPS Growth Rate (%)-89.20%
Profit Margin3.27%
Total Equity (US$ Millions)$1,383
Return on Equity (%)17.83%
Long Term Debt (US$ Millions)$18,035
Debt To Equity Ratio (%)13.04%
Total Assets (US$ Millions)$72,678
Current Assets (US$ Millions)$20,557
Current Liabilities (US$ Millions)$23,374
Cost of Goods Sold (US$ Millions)$11,428
Inventory Turnover1.89